Merck & Co. Strengthens its HIV Pipeline with Two Licensing Deals
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 7 (Table of Contents)
Published: 30 Jul-2012
DOI: 10.3833/pdr.v2012.i7.1785 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In its first major deal, Chimerix has granted Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018